Correlation Between Mineralys Therapeutics, and PureTech Health
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and PureTech Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and PureTech Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and PureTech Health PLC, you can compare the effects of market volatilities on Mineralys Therapeutics, and PureTech Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of PureTech Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and PureTech Health.
Diversification Opportunities for Mineralys Therapeutics, and PureTech Health
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mineralys and PureTech is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and PureTech Health PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PureTech Health PLC and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with PureTech Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PureTech Health PLC has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and PureTech Health go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and PureTech Health
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the PureTech Health. In addition to that, Mineralys Therapeutics, is 1.42 times more volatile than PureTech Health PLC. It trades about -0.09 of its total potential returns per unit of risk. PureTech Health PLC is currently generating about -0.07 per unit of volatility. If you would invest 2,056 in PureTech Health PLC on November 4, 2024 and sell it today you would lose (200.00) from holding PureTech Health PLC or give up 9.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. PureTech Health PLC
Performance |
| Timeline |
| Mineralys Therapeutics, |
| PureTech Health PLC |
Mineralys Therapeutics, and PureTech Health Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and PureTech Health
The main advantage of trading using opposite Mineralys Therapeutics, and PureTech Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, PureTech Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PureTech Health will offset losses from the drop in PureTech Health's long position.The idea behind Mineralys Therapeutics, Common and PureTech Health PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| PureTech Health vs. Molecular Partners AG | PureTech Health vs. MediciNova | PureTech Health vs. Anebulo Pharmaceuticals | PureTech Health vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |